Annual report [Section 13 and 15(d), not S-K Item 405]

Income Taxes

v3.26.1
Income Taxes
 12 Months Ended
Dec. 31, 2025
Income Taxes [Abstract]  
INCOME TAXES

NOTE 9 – INCOME TAXES

 

The Company accounts for income taxes under ASC 740 - Income Taxes (“ASC 740”), which provides for an asset and liability approach of accounting for income taxes. Under this approach, deferred tax assets and liabilities are recognized based on anticipated future tax consequences, using currently enacted tax laws, attributed to temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts calculated for income tax purposes.

Significant components of the Company’s deferred tax assets as of December 31, 2025, and 2024 are summarized below.

 

    Year Ended December 31,  
    2025     2024  
Deferred tax assets:            
Amortization   $ 148,000     $
-
  
Research & development costs     4,286,000       2,917,000  
Warrant liabilities     11,000       40,000  
Stock-based compensation     345,000       307,000  
Net operating loss carryforwards     11,025,000       8,126,000  
Federal R&D tax credit     368,000       419,000  
Total deferred tax assets     16,183,000       11,809,000  
Deferred tax liabilities:                
Amortization    
-
       (83,000 )
Depreciation    
-
       (28,000 )
Net deferred tax assets     16,183,000       11,698,000  
Valuation allowance     (16,183,000 )     (11,698,000 )
    $
-
     $
-
  

 

The Company recognizes deferred tax assets to the extent that it believes that these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. The Company assessed the need for a valuation allowance against its net deferred tax assets and determined a full valuation allowance is required since the Company has no history of generating taxable income. Our deferred tax asset and valuation allowance increased by $4,485,000 and $4,084,000 for the years ended December 31, 2025, and 2024, respectively.

 

A reconciliation of the federal income tax rate to the Company’s effective tax rate at December 31, 2025, and 2024 is as follows:

 

    December 31,  
    2025     2024  
             
Statutory federal income tax rate     21.00 %     21.00 %
State taxes, net of federal tax benefit     0.00 %     -0.10 %
Stock-based compensation     -0.10 %     -0.60 %
Return to provision adjustment     0.20 %     0.20 %
Permanent items     0.00 %     0.00 %
R&D credit generated     -0.30 %     1.70 %
Other     0.50 %     0.00 %
Change in valuation allowance     -19.80 %     -22.30 %
Income tax provision     1.50 %     -0.10 %

 

The Company’s ability to utilize net operating loss carryforwards will depend on its ability to generate adequate future taxable income. Future utilization of the net operating loss carry forwards is subject to certain limitations under Section 382 of the Internal Revenue Code. As of December 31, 2025, the Company had federal and state net operating loss carryforwards available to offset future taxable income in the amounts of approximately $11,025,000 and $34,610,000, respectively, which do not expire.

 

The Company has evaluated its income tax positions and has determined that it does not have any uncertain tax positions. The Company will recognize interest and penalties related to any uncertain tax position through its income tax expense.

 

The Company is subject to franchise tax filing requirements in the State of Delaware.